Prescriber's Letter | Unbiased Medication Updates & CME

July 2025 Issue

Shed Light on Sunscreen Rumors

People still have burning questions about sunscreen...

Resources

FAQ: Shedding Light on Questions About Sunscreens

Clarify Absolute and Relative Risk for Learners

You can help students and residents put risk in perspective when evaluating study results...

Stay in Step With Treatments for Restless Legs Syndrome

Dopamine agonists (ropinirole, etc) are no longer first-line for restless legs syndrome (RLS)...

Expect Questions About Cetirizine and Phenazopyridine Safety

Recent news will bring up questions about some commonly used OTCs...

GO TO FULL ISSUE

CE & Training

NEW REQUIRED COURSE: Cannabinoids: Efficacy and Safety

CE-IN-THE-LETTER: Prescriber Insights July 2025

LIVE CE: Mastering Meds After Acute Coronary Syndromes

PODCAST CE: Medication Talk - Meds for Alzheimer Dementia

GO TO CE & TRAINING ORGANIZER

Featured Clinical Resources

Your top priority is what's best for patients. So is ours.

Group Purchases & Pricing

Prescriber Insights is eligible for bulk discounts. Customize CE and compliance training assignments. Easily manage users and run reports. Bundle with other products for significant savings. Request information

GO TO FULL PODCAST >